search icon
dcoy-img

Decoy Therapeutics Inc Share Price

DCOY
NAQ
$0.776
+$0.01
(1.3%)
1D
Sector: Healthcare

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$0
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
59.67K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.51 L
$0.9 H
$0.776

About Decoy Therapeutics Inc, Common Stock

Salarius Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on advancing its pipeline of peptide conjugate therapeutics engineered through its IMP3ACT platform that reduces the complexity of drug development and manufacturing. It is focused on developing effective treatments for patients with cancer with high, unmet medical needs. The company’s lead candidate, seclidemstat (SP-2577), is being studied as treatment for pediatric cancers, sarcomas, and other cancers with limited treatment options. Its pipeline consists of SP-3164 a targeted protein degrader and seclidemstat (SP-2577), a targeted protein inhibitor. SP-3164 is a next-generation cereblon-binding MG. SP-2577 is a small-molecule LSD1 inhibitor with a novel scaffold. more

Sector: Healthcare

Returns

Data is not properly formatted.

Ratios

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

DCOY
ROA (LTM) 0.00%
ROE (LTM) 0.00%

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

DCOY
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 0.00
EV/R 0.00
EV/Ebitda NM

FAQs

What is Decoy Therapeutics Inc share price today?

Decoy Therapeutics Inc (DCOY) share price today is $0.776

Can Indians buy Decoy Therapeutics Inc shares?

Yes, Indians can buy shares of Decoy Therapeutics Inc (DCOY) on Vested. To buy from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in DCOY stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Decoy Therapeutics Inc be purchased?

Yes, you can purchase fractional shares of Decoy Therapeutics Inc (DCOY) via the Vested app. You can start investing in Decoy Therapeutics Inc (DCOY) with a minimum investment of $1.

How to invest in Decoy Therapeutics Inc shares from India?

You can invest in shares of Decoy Therapeutics Inc (DCOY) via Vested in three simple steps:

  • Click on Sign Up or Invest in DCOY stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Decoy Therapeutics Inc shares

What is Decoy Therapeutics Inc 52-week high and low stock price?

The 52-week high price of Decoy Therapeutics Inc (DCOY) is $0.9. The 52-week low price of Decoy Therapeutics Inc (DCOY) is $0.51.

What is Decoy Therapeutics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Decoy Therapeutics Inc (DCOY) is

What is Decoy Therapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Decoy Therapeutics Inc (DCOY) is 0.00

What is Decoy Therapeutics Inc dividend yield?

The dividend yield of Decoy Therapeutics Inc (DCOY) is 0.00%

What is the Market Cap of Decoy Therapeutics Inc?

The market capitalization of Decoy Therapeutics Inc (DCOY) is

What is Decoy Therapeutics Inc's stock symbol?

The stock symbol (or ticker) of Decoy Therapeutics Inc is DCOY

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top